David A. Braun, MD, PhD

David A. Braun, MD, PhD, specializes in medical oncology and hematology, focusing on the treatment of kidney cancers.

As an assistant professor of medicine at Yale School of Medicine, Dr. Braun is dedicated to advancing the understanding and application of immune therapies in kidney cancer.

Immune therapy is a treatment that helps the body’s own defense system, the immune system, fight cancer. Normally, the immune system might not recognize cancer cells because they can disguise themselves. Immune therapy works by removing the "brakes" that prevent the immune system from attacking cancer, allowing it to better target and destroy cancer cells.

Dr. Braun’s research involves exploring how the environment around kidney cancer cells affects treatment and finding specific targets on cancer cells to develop personalized therapies for diseases like renal cell carcinoma.

Dr. Braun received his doctoral degree in computational biology from New York University and his medical degree from the Icahn School of Medicine at Mount Sinai. He completed his residency at Brigham and Women's Hospital and a fellowship in adult oncology through the Dana-Farber/Partners Cancer Care program.